Hybridization of Promoter DNA Targets in Chromatin to Discover Regulatory Protein

染色质中的启动子 DNA 靶标杂交以发现调节蛋白

基本信息

  • 批准号:
    7892575
  • 负责人:
  • 金额:
    $ 20.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2012-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chromatin immunoprecipitation (ChIP) is a powerful tool for investigating the mechanisms through which nuclear proteins influence gene regulation. ChIP can be used to determine whether or not a particular protein is present in the in the chromatin of a living cell, to localize the region of interaction of a protein within the genomic DNA, and to isolate chromatin fragments that contain a particular target. However, since the basis of ChIP is the recognition of particular proteins or functional groups, it is limited in its ability to interrogate the full complement of proteins in a specific genomic region. In order to overcome this limitation, we propose to develop new approaches to analysis of chromatin that uses hybridization probes to target specific DNA sequences rather than antibody-based recognition. Our particular interest is in genomic DNA that may form alternate structures during nuclear processes, specifically in this application in gene promoter regions that contain G-rich sequences known to form G-quadruplex structures in vitro. These regions are the focus of much speculation and growing investigation in the cancer research community. The specific aims for this project period are to (1) demonstrate feasibility and selectivity and optimize conditions for in vivo capture of target chromatin DNA and associated proteins using chromatin antisense rehybridization (CAR) and chromatin sense rehybridization (CSR) with the model system of the insulin- linked polymorphic region (ILPR), and (2) evaluate the effectiveness of CAR and CSR to probe the proteins associated with the human c-myc oncogene promoter region in both cancer and normal cells. The proposed CAR/CSR techniques should be adaptable to isolation of target DNA and associated proteins in any genomic region of interest, and will be an important addition to the chromatin analysis toolbox. They will complement ChIP techniques by targeting specific DNA sequences rather than specific antibody targets such as proteins, thereby enabling discovery of new protein interactions that participate in gene regulation. There is exciting potential for discovery in epigenetic regulation as well. We propose to develop new approaches to analysis of chromatin, the genetic material in the nucleus of the living cell that uses hybridization probes to target specific DNA sequences rather than antibody-based recognition of immunochemical targets. Identification of the full complement of proteins associated with a particular DNA target of interest such as a gene promoter region in chromatin will lead to a better understanding of gene regulation and to the discovery of new biomarkers and drug targets.
描述(申请人提供):染色质免疫沉淀(CHIP)是研究核蛋白影响基因调控机制的有力工具。芯片可以用来确定活细胞的染色质中是否存在特定的蛋白质,定位基因组DNA中蛋白质相互作用的区域,以及分离包含特定靶点的染色质片段。然而,由于芯片的基础是识别特定的蛋白质或功能基团,它在询问特定基因组区域的全部蛋白质的能力方面是有限的。为了克服这一限制,我们建议开发新的染色质分析方法,使用杂交探针来靶向特定的DNA序列,而不是基于抗体的识别。我们特别感兴趣的是在核过程中可能形成替代结构的基因组DNA,特别是在这一应用中,基因启动子区域包含已知在体外形成G-四链结构的富含G的序列。这些区域是癌症研究界许多猜测和越来越多的调查的焦点。本项目期间的具体目标是(1)论证可行性和选择性,并优化使用染色质反义再杂交(CAR)和染色质正义再杂交(CSR)结合胰岛素连接多态区域(ILPR)模型系统在体内捕获目标染色质DNA和相关蛋白质的条件;(2)评估CAR和CSR在探测癌细胞和正常细胞中与人c-myc癌基因启动子区域相关的蛋白质的有效性。建议的CAR/CSR技术应该适用于分离目标DNA和任何感兴趣的基因组区域的相关蛋白质,并将是染色质分析工具箱的重要补充。它们将通过针对特定的DNA序列而不是特定的抗体目标(如蛋白质)来补充芯片技术,从而能够发现参与基因调控的新的蛋白质相互作用。在表观遗传调控方面也有令人兴奋的发现潜力。我们建议开发新的方法来分析染色质,染色质是活细胞核中的遗传物质,它使用杂交探针来靶向特定的DNA序列,而不是基于抗体识别免疫化学目标。识别与特定DNA靶点相关的全部蛋白质,如染色质中的基因启动子区域,将有助于更好地理解基因调控,并发现新的生物标志物和药物靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Linda B. Mc GOWN其他文献

Linda B. Mc GOWN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Linda B. Mc GOWN', 18)}}的其他基金

Genome-Inspired Pathway to Aptamer Discovery
基因组启发的适体发现途径
  • 批准号:
    9313901
  • 财政年份:
    2015
  • 资助金额:
    $ 20.44万
  • 项目类别:
Genome-Inspired Pathway to Aptamer Discovery
基因组启发的适体发现途径
  • 批准号:
    9134167
  • 财政年份:
    2015
  • 资助金额:
    $ 20.44万
  • 项目类别:
Genome-Inspired Pathway to Aptamer Discovery
基因组启发的适体发现途径
  • 批准号:
    8961141
  • 财政年份:
    2015
  • 资助金额:
    $ 20.44万
  • 项目类别:
Two-Dimensional Microfluidic Platform for Rapid DNA Separation by Fragment Length
用于按片段长度快速分离 DNA 的二维微流控平台
  • 批准号:
    8531295
  • 财政年份:
    2012
  • 资助金额:
    $ 20.44万
  • 项目类别:
Two-Dimensional Microfluidic Platform for Rapid DNA Separation by Fragment Length
用于按片段长度快速分离 DNA 的二维微流控平台
  • 批准号:
    8717690
  • 财政年份:
    2012
  • 资助金额:
    $ 20.44万
  • 项目类别:
Two-Dimensional Microfluidic Platform for Rapid DNA Separation by Fragment Length
用于按片段长度快速分离 DNA 的二维微流控平台
  • 批准号:
    8352837
  • 财政年份:
    2012
  • 资助金额:
    $ 20.44万
  • 项目类别:
Hybridization of Promoter DNA Targets in Chromatin to Discover Regulatory Protein
染色质中的启动子 DNA 靶标杂交以发现调节蛋白
  • 批准号:
    7692463
  • 财政年份:
    2009
  • 资助金额:
    $ 20.44万
  • 项目类别:
Affinity Interactions Between Insulin and Quadruplex DNA
胰岛素和四链体 DNA 之间的亲和力相互作用
  • 批准号:
    7025052
  • 财政年份:
    2005
  • 资助金额:
    $ 20.44万
  • 项目类别:
Affinity Interactions Between Insulin and Quadruplex DNA
胰岛素和四链体 DNA 之间的亲和力相互作用
  • 批准号:
    6903343
  • 财政年份:
    2005
  • 资助金额:
    $ 20.44万
  • 项目类别:
Proteomic Approach to G-Quartets and Cell Aging
G-四重奏和细胞衰老的蛋白质组学方法
  • 批准号:
    6576620
  • 财政年份:
    2002
  • 资助金额:
    $ 20.44万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 20.44万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 20.44万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 20.44万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.44万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 20.44万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 20.44万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 20.44万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 20.44万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 20.44万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 20.44万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了